Overview

A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System

Status:
Completed
Trial end date:
2018-04-02
Target enrollment:
Participant gender:
Summary
A study to assess the skin irritation and sensitization potential of Corplex™ Donepezil Transdermal Delivery System (TDS)
Phase:
Phase 1
Details
Lead Sponsor:
Corium International Inc.
Corium, Inc.
Treatments:
Donepezil